Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Medicine and Dentistry
Pediatrics
100%
Liquid Biopsy
91%
Solid Malignant Neoplasm
81%
Neoplasm
53%
Rhabdomyosarcoma
47%
Ganglioneuroblastoma
46%
Biological Marker
44%
Cell-Free DNA
41%
Droplet Digital Polymerase Chain Reaction
38%
Patient with Neuroblastoma
24%
Messenger RNA
21%
Pediatrics Patient
20%
Intracranial Tumor
20%
Systematic Review
18%
Disseminated Disease
16%
Risk Stratification
16%
Tumor Marker
15%
Metastatic Carcinoma
13%
Event Free Survival
13%
Size-Exclusion Chromatography
10%
Real-Time Polymerase Chain Reaction
10%
RNA Directed DNA Polymerase
10%
Pediatric Cancer
10%
Malignant Neoplasm
10%
Fusion Gene
9%
Ewing Sarcoma
8%
Wilms' Tumor
8%
Reduced Representation Bisulfite Sequencing
8%
Minimal Residual Disease
7%
In Vitro
6%
Blood Brain Barrier
6%
Clinical Study
6%
Specific Tumor
6%
Cerebrospinal Fluid
5%
Kidney Tumour
5%
Whole Genome Sequencing
5%
CHRNA3
5%
Localized Disease
5%
Cell Cycle Regulation
5%
Cell Cycle
5%
Platelet
5%
Invasive Diagnostics
5%
Thrombocyte Poor Plasma
5%
Nucleic Acid
5%
Childhood Cancer
5%
Keyphrases
Liquid Biopsy
87%
Pediatric Tumors
81%
Cell-free DNA (cfDNA)
34%
Rhabdomyosarcoma
34%
Droplet Digital PCR (ddPCR)
32%
RASSF1A
32%
Neuroblastoma
31%
Extracellular Vesicles
29%
Tumor
23%
Pediatric Patients
19%
Prognostic Biomarker
19%
Diagnostic Biomarker
17%
Pediatric Rhabdomyosarcoma
16%
Targeted Locus Amplification
16%
Molecular Detection
16%
Disseminated Infection
16%
Technical Potential
16%
Patient-specific
16%
Cell-free RNA
16%
Risk Stratification
16%
Clinical Potential
16%
Brain Tumor Patients
16%
Ultrasound-enhanced
16%
Diagnostic Tool
16%
Focused Ultrasound
16%
Material Reference
16%
Quantitative PCR
14%
Confidence Interval
13%
Specific Marker
12%
Working Diagnosis
10%
Reverse Transcriptase
10%
Bone Marrow
10%
Event-free Survival
10%
Brain Tumor
9%
Plasma Samples
9%
Fusion Gene
9%
Ewing Sarcoma
8%
Metastatic Disease
8%
Tumor Biomarkers
8%
Blood-brain Barrier
8%
Peripheral Blood
7%
Multiplex
6%
Tumor-specific
6%
Region of Interest
6%
Healthy Controls
6%
PCR Assay
6%
Size Exclusion Chromatography
6%
Minimally Invasive
5%
Diagnostic Potential
5%
Primary Brain Tumor
5%
